PDIA3 and Alzheimer disease: An overall analysis by two-way ANOVA, with genotype (3×Tg-AD vs. Non-Tg) and age (6 months of age vs. 18 months of age) as between-subject factors, indicated that both factors may contribute to the alteration of PDIA3 protein expression in the limbic brain regions (Table 1).